A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
Recruiting · NCT05420948 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer | Cancer of Head, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-05-12 | NCT05420948 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Chicago | 326 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Chicago Comprehensive Cancer Center | Chicago | United States | 273 |